Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam C Berger

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Journal of the American College of Surgeons|April 6, 2011
Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomyAdam C Berger, Aaron Bloomenthal, Benny Weksler, et al.
Cancer Research|December 11, 2012
TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cellsMichele B Weiss, Ethan V Abel, Melanie M Mayberry, et al.
Journal of Surgical Oncology|October 18, 2013
Outcomes in patients with mucosal melanomasDeborah S Keller, Alan A Thomay, John Gaughan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2010
Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?Shannon E Fogh, Anthony Yu, Gregory J Kubicek, et al.
Surgical Endoscopy|June 24, 2017
A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeownAndrew M Brown, Michael J Pucci, Adam C Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2005
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survivalAdam C Berger, Jeffrey Farma, Walter J Scott, et al.
Journal of Surgical Oncology|May 3, 2017
Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume centerDanica N Giugliano, Andrew Morgan, Francesco Palazzo, et al.
Journal of Surgical Oncology|August 5, 2011
Lymph node ratio is an important and independent prognostic factor for patients with stage III melanomaAdam C Berger, Michael Fierro, John C Kairys, et al.
The Journal of Investigative Dermatology|March 12, 2016
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS MelanomaHa Linh Vu, Sheera Rosenbaum, Claudia Capparelli, et al.
Radiology|May 4, 2017
Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary ExperienceKibo Nam, John R Eisenbrey, Maria Stanczak, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Journal of the American College of Surgeons|April 6, 2011
Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomyAdam C Berger, Aaron Bloomenthal, Benny Weksler, et al.
Cancer Research|December 11, 2012
TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cellsMichele B Weiss, Ethan V Abel, Melanie M Mayberry, et al.
Journal of Surgical Oncology|October 18, 2013
Outcomes in patients with mucosal melanomasDeborah S Keller, Alan A Thomay, John Gaughan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2010
Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?Shannon E Fogh, Anthony Yu, Gregory J Kubicek, et al.
Surgical Endoscopy|June 24, 2017
A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeownAndrew M Brown, Michael J Pucci, Adam C Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2005
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survivalAdam C Berger, Jeffrey Farma, Walter J Scott, et al.
Journal of Surgical Oncology|May 3, 2017
Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume centerDanica N Giugliano, Andrew Morgan, Francesco Palazzo, et al.
Journal of Surgical Oncology|August 5, 2011
Lymph node ratio is an important and independent prognostic factor for patients with stage III melanomaAdam C Berger, Michael Fierro, John C Kairys, et al.
The Journal of Investigative Dermatology|March 12, 2016
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS MelanomaHa Linh Vu, Sheera Rosenbaum, Claudia Capparelli, et al.
Radiology|May 4, 2017
Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary ExperienceKibo Nam, John R Eisenbrey, Maria Stanczak, et al.
Pageof 14